AGP Executive Report
Last update: 10 hours agoHepatitis B Trial: Danish researchers are defending a proposed study involving 14,000 newborns in Guinea-Bissau. The revised plan has reportedly received ethics approval in Denmark and Guinea-Bissau, but the health minister says the government has not authorized it. The study would compare a birth dose of the vaccine with vaccination at six weeks, the current local practice. Critics warn that delaying a proven vaccine could leave some babies vulnerable to infection in a country where hepatitis B is widespread.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.